B

Bioventus Inc
NASDAQ:BVS

Watchlist Manager
Bioventus Inc
NASDAQ:BVS
Watchlist
Price: 6.52 USD -0.31% Market Closed
Market Cap: 535.6m USD

Wall Street
Price Targets

BVS Price Targets Summary
Bioventus Inc

Wall Street analysts forecast BVS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BVS is 14.28 USD with a low forecast of 12.12 USD and a high forecast of 15.75 USD.

Lowest
Price Target
12.12 USD
86% Upside
Average
Price Target
14.28 USD
119% Upside
Highest
Price Target
15.75 USD
142% Upside
Bioventus Inc Competitors:
Price Targets
HARTA
Hartalega Holdings Bhd
74% Upside
YPSN
Ypsomed Holding AG
22% Upside
POLYMED
Poly Medicure Ltd
31% Upside
7741
Hoya Corp
28% Upside
XVIVO
Xvivo Perfusion AB
96% Upside
MED
Medartis Holding AG
5% Upside
7979
Shofu Inc
41% Upside

Revenue
Forecast

Revenue Estimate
Bioventus Inc

For the last 10 years the compound annual growth rate for Bioventus Inc's revenue is 9%. The projected CAGR for the next 3 years is 3%.

9%
Past Growth
3%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bioventus Inc

The compound annual growth rate of Bioventus Inc's operating income for the next 3 years is 72%.

N/A
Past Growth
72%
Estimated Growth
Estimates Accuracy
-74%
Average Miss

Net Income
Forecast

Net Income Estimate
Bioventus Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-68%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BVS's stock price target?
Price Target
14.28 USD

According to Wall Street analysts, the average 1-year price target for BVS is 14.28 USD with a low forecast of 12.12 USD and a high forecast of 15.75 USD.

What is Bioventus Inc's Revenue forecast?
Projected CAGR
3%

For the last 10 years the compound annual growth rate for Bioventus Inc's revenue is 9%. The projected CAGR for the next 3 years is 3%.

What is Bioventus Inc's Operating Income forecast?
Projected CAGR
72%

The compound annual growth rate of Bioventus Inc's operating income for the next 3 years is 72%.

Back to Top